FactoryRegistry
Claim a page

Bristol-myers Squibb Company

Claim this page
www.bms.com
Homepage of Bristol-myers Squibb Company
Their homepage, crawled JUL 30, 2026
At a glance
Employees500+
In business sinceNot reported
HeadquartersLawrenceville, NJ
US patents3,751
SAM.gov UEIUFGKB2B71N12
CAGE code4K2D9
Incorporated inDE
LEIHLYYNH7UQUORYSJQCN42
LISTED ON FACTORYREGISTRY100%SOURCE COVERAGE
Named on the company’s own website, read JUL 29, 2026

Open positions

Openings read from Bristol-myers Squibb Company’s own job board on Workday, last checked NOV 15, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.

1,270 more on the company’s board

Supplier designations

For Profit OrganizationManufacturer of Goods

Self-certified by the company in its SAM.gov registration

Terms of sale

PricingUnless otherwise agreed in writing, the Price: (a) is fixed in CZK and is not subject to any incremental cost as a result of currency fluctuations;

Unless otherwise agreed in writing, the Price: (a) is fixed in CZK and is not subject to any incremental cost as a result of currency fluctuations; (b) is inclusive of all requirements resulting from set up "terms of sale" (c) is exclusive of VAT at the rate established by the Czech Republic law, which is stated on the invoice; (d) Any change in the set Price will be notified in writing to the Purchaser 14 days prior to effective date of such a change. 4.2. The Purchaser shall pay all undisputed amounts within the due date as set out on the respective invoice. If the payment due date falls on a day which is not a business day, then the payment due date 4.3. If the Purchaser fails to pay an undisputed invoice by the due date for payment, described in clause 4.1 above, the Seller may charge default interest on the unpaid amount at the rate and in the manner prescribed by Czech law from the due date until the date of actual payment. 4.4. Notwithstanding the above, other terms of payment may be set up by the Seller and communicated to the Purchaser in a written form. 5. TITLE OF PRODUCTS OWNERSHIP 5.1. Place and time of the transfer of the Products ownership are determined by "Terms of sale". The ownership to the Products, free of prior rights or interests of the Seller, passes to the Purchaser upon the delivery of the

“Unless otherwise agreed in writing, the Price” · Standardni obchodni podminky BMS Ceska republika 10.2024 · open the document (PDF)

Cancellation and returnsPurchaser in conformance with the Purchase Order. 3.2. The Seller shall inform the Purchaser on the unavailability of the ordered Products and anticipated deadline for providing…

Purchaser in conformance with the Purchase Order. 3.2. The Seller shall inform the Purchaser on the unavailability of the ordered Products and anticipated deadline for providing to the Purchaser the remaining part of the Purchase Order. 3.3. Upon arrival of the Products at the Purchaser's pharmaceutical warehouse, the Purchaser shall check the delivery for possible quantitative shortcomings and damage. Should the Products be in recognizably defective state or should quantitative shortcomings be detected, the Purchaser shall immediately inform the Seller and cooperate with the Seller in solving the issues caused by the defects. The above obligation shall not apply to the Products with hidden defects, however the Purchaser shall notify such hidden defects to the Seller in the form of a complaint protocol, providing detailed information pertaining to the Product, delivery and defects found, immediately after discovery of the defect and shall provide all necessary assistance that may be reasonably requested by the Seller in this regard. 3.4. In the event that upon the arrival of the Products at the Purchaser’s warehouse it is determined that the Products are in recognizably defective state, the

“Purchaser in conformance with the Purchase Order” · Standardni obchodni podminky BMS Ceska republika 10.2024 · open the document (PDF)

From Bristol-myers Squibb Company’s own terms and conditions of sale · read October 18, 2026 · not verified by FactoryRegistry

Patents

3,751 US patents granted 1990–2025, 429 of them in the five years to SEP 2025, including 56 design patents.

Pharmaceuticals 1,990Organic fine chemistry 1,149Biotechnology 193Medical technology 164Measurement 103

Newest 5 shown · Granted to Bristol-Myers Squibb Company · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0

Their plants

20 FACILITIES
FacilityCityStateEmployeesStatus
Bristol-myers Squibb Research & DevelopmentWallingfordCT— REPORTED CLOSED
Bristol Myers SquibbLibertyvilleIL— UNVERIFIED
Bristol Myers Squibb LibertyvilleLibertyvilleIL— UNVERIFIED
Bristol Myers Squibb Company IncorporatedMount VernonIN— LIKELY ACTIVE
Bristol-myers Squibb CODevensMA500+ LIKELY ACTIVE
Bristol-myers Squibb CO - Princeton Pike SiteLawrence TwpNJ— UNVERIFIED
Bristol-myers Squibb CompanyLawrencevilleNJ— ACTIVE
Bristol Myers SquibbLawrencevilleNJ— UNVERIFIED
Bristol Myers SquibbNew BrunswickNJ— UNVERIFIED
Bristol-myers Squibb CompanyPenningtonNJ— LIKELY ACTIVE
Bristol Myers Squibb - Summit West Cell Therapy ManufacturingSummitNJ500+ LIKELY ACTIVE
Bristol-myers Squibb CompanyGarden CityNY— UNVERIFIED
Bristol-myers Squibb CompanySyracuseNY— LIKELY ACTIVE
Bristol Myers Squibb CO.BarcelonetaPR— UNVERIFIED
Bristol-myers Squibb Manufacturing COBarcelonetaPR— UNVERIFIED
Bristol-Myers Squibb - Puerto Rico GuaynaboGuaynaboPR20–99 LIKELY ACTIVE
Bristol Myers Squibb Manufacturing COHumacaoPR— LIKELY ACTIVE
Bristol Myers SquibbManatiPR— UNVERIFIED
Bristol-myers Squibb Holding PharmaManatiPR500+ ACTIVE
Bristol Myers Squibb Cell Therapy OperationsBothellWA500+ LIKELY ACTIVE

WARN Act notices

Filed with the state under the federal WARN Act · WARN Act notices feed, CC BY 4.0

Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.